Literature DB >> 17330782

Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals.

Nanhua Chen1, Alyson Auliff, Karl Rieckmann, Michelle Gatton, Qin Cheng.   

Abstract

Plasmodium vivax infections are characterized by varying numbers of relapses occurring at different intervals as a result of activation of liver-stage hypnozoites. Parasite or host factors that determine the number and timing of relapses are unclear. In the present article, we report the analysis of relapse patterns and molecular characterization of parasites collected from Australian soldiers experiencing relapses of vivax malaria after exposure in East Timor. Although high molecular diversity was observed, a single allelic type was identified in association with 99% of relapses. Importantly, in 71% of patients experiencing >1 relapse, the allelic types were clonal and different in the 2 different relapses. These results, combined with those from a computer simulation model, suggest that a single hypnozoite clone was activated, causing a relapse, and that multiple relapses most likely arose from coordinated activation of hypnozoites originating from different parasite strains. These findings suggest remarkable regulation of relapse intervals in vivax malaria.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17330782     DOI: 10.1086/512242

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  93 in total

Review 1.  The hypnozoite concept, with particular reference to malaria.

Authors:  Miles B Markus
Journal:  Parasitol Res       Date:  2010-10-06       Impact factor: 2.289

2.  Can estimates of antimalarial efficacy from field studies be improved?

Authors:  Michelle L Gatton; Qin Cheng
Journal:  Trends Parasitol       Date:  2008-01-07

Review 3.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

4.  Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax.

Authors:  R Suwanarusk; M Chavchich; B Russell; A Jaidee; F Chalfein; M Barends; B Prasetyorini; E Kenangalem; K A Piera; U Lek-Uthai; N M Anstey; E Tjitra; F Nosten; Q Cheng; R N Price
Journal:  J Infect Dis       Date:  2008-11-15       Impact factor: 5.226

Review 5.  Strain theory of malaria: the first 50 years.

Authors:  F Ellis McKenzie; David L Smith; Wendy P O'Meara; Eleanor M Riley
Journal:  Adv Parasitol       Date:  2008       Impact factor: 3.870

Review 6.  Malaria in the Traveler: How to Manage Before Departure and Evaluate Upon Return.

Authors:  William O Hahn; Paul S Pottinger
Journal:  Med Clin North Am       Date:  2016-01-14       Impact factor: 5.456

7.  Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.

Authors:  Céline Barnadas; Arsène Ratsimbasoa; Magali Tichit; Christiane Bouchier; Martial Jahevitra; Stéphane Picot; Didier Ménard
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

8.  Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children.

Authors:  Jennifer L Cole-Tobian; Pascal Michon; Moses Biasor; Jack S Richards; James G Beeson; Ivo Mueller; Christopher L King
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

Review 9.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

10.  Microgeographically diverse Plasmodium vivax populations at the Thai-Myanmar border.

Authors:  Bhavna Gupta; Daniel M Parker; Qi Fan; B P Niranjan Reddy; Guiyun Yan; Jetsumon Sattabongkot; Liwang Cui
Journal:  Infect Genet Evol       Date:  2016-09-28       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.